Okay, let's tackle this question. The user provided a question about drugs metabolized by acetylation and wants a detailed explanation. The correct answer is missing, so first, I need to figure out which drug isn't metabolized by acetylation.

Acetylation is a phase II metabolic reaction, typically involving the enzyme N-acetyltransferase. Common drugs that undergo acetylation include isoniazid, sulfonamides, hydralazine, and procainamide. These are all substrates for NAT2, the enzyme responsible for acetylation.

The question asks for the exception. Let's think of drugs that are metabolized by other pathways. For example, phenacetin is metabolized by cytochrome P450 enzymes, not acetylation. Alternatively, maybe something like dapsone, but I think dapsone is acetylated. Wait, no, dapsone is metabolized by glucuronidation. Hmm.

Wait, another possibility: maybe the answer is a drug that's primarily metabolized by oxidation. Let me recall. Isoniazid is acetylated. Sulfamethoxazole is acetylated. Procainamide is acetylated. So the exception would be a drug that's not processed this way.

Wait, maybe the options include a drug like aspirin, which is primarily metabolized by hydrolysis. Or perhaps phenytoin, which is metabolized by CYP enzymes. Let me check. If the options are A. Isoniazid, B. Sulfamethoxazole, C. Procainamide, D. Phenytoin. Then D would be the correct answer because phenytoin is metabolized by CYP2C9.

So the correct answer is the drug that isn't acetylated. The question is testing knowledge of acetylation pathways. The core concept is phase II metabolism via acetylation. The correct answer is the one not metabolized by NAT2. The distractors are acetylated drugs. The clinical pearl is to remember the common acetylated drugs and the enzyme involved. Need to ensure that the explanation clearly differentiates the correct answer from the others.

**Core Concept**
Acetylation is a phase II metabolic pathway catalyzed by **N-acetyltransferase (NAT)** enzymes, primarily NAT2. It conjugates acetyl groups to aromatic amines and hydrazines, affecting drug clearance and toxicity. Slow acetylator phenotypes (genetic polymorphism) influence drug metabolism variability.

**Why the Correct Answer is Right**
**Phenytoin** is metabolized via **cytochrome P450 (CYP2C9/2C19)** enzymes, not acetylation. Its metabolism involves hydroxylation and conjugation, making it unrelated to NAT2 activity. This distinguishes it from other drugs (e.g., isoniazid, sulfonamides) that undergo acetylation.

**Why Each Wrong Option is Incorrect**
**Option A: Isoniazid** – Incorrect. Isoniazid is a classic substrate of NAT2, acetylated in the liver.
**Option B: Sulfamethoxazole** – Incorrect. Sulfonamides like sulfamethoxazole undergo acetylation, forming ac

✓ Correct Answer: C. Ketoconazole